Trade

Blue Jet Healthcare share price

High risk
  • 56%Low risk
  • 56%Moderate risk
  • 56%Balanced risk
  • 56%High risk
  • 56%Extreme risk
  • 907.75(-0.87%)
    July 11, 2025 15:45:28 PM IST
    • NSE
    • BSE
  • Vol : 382.21K (NSE + BSE)
    Last 20 day avg : 307.03 K

Blue Jet Healthcare is trading -0.87% lower at Rs 907.75 as compared to its last closing price. Blue Jet Healthcare has been trading in the price range of 943.25 & 905.85. Blue Jet Healthcare has given 62.41% in this year & 5.57% in the last 5 days. Blue Jet Healthcare has TTM P/E ratio 50.28 as compared to the sector P/E of 22.90.There are 6 analysts who have initiated coverage on Blue Jet Healthcare. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 110.10 Crores in its last quarter.Listed peers of Blue Jet Healthcare include Niva Bupa Health Insurance (-2.01%), Acme Solar Holdings (2.44%), Blue Jet Healthcare (-0.87%).The Mutual Fund holding in Blue Jet Healthcare was at 0.62% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Blue Jet Healthcare was at 2.28% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 12, 2025, 03:41 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.13
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    13.74
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    50.98
    Higher than historical values
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Higher than industry
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
905.85
Highest
943.25
52 week range
Lowest
400.05
Highest
985.60
Blue Jet Healthcare Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company has grown its March quarter profit by 177.67% from Rs 39.65 crore to Rs 110.10 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Blue Jet Healthcare Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 938.23
  • R2
  • 997.92
  • R3
  • 1,052.58
Pivot883.57
  • S1
  • 823.88
  • S2
  • 769.22
  • S3
  • 709.53
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Blue Jet Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Niva Bupa Health Insurance
Bullish
88.54-2.0116,336.1268.313.97-6.62
Acme Solar Holdings
Bullish
295.552.4417,883.3651.923.350.08229.73
Blue Jet Healthcare
Bullish
907.75-0.8715,746.3249.3913.30.121.46
Doms Industries
Bearish
2,355.50-1.8314,328.6374.1014.940.1014.83
Cello World
Moderately Bullish
625.40-2.0213,912.6040.066.330.240.22
Blue Jet Healthcare Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Blue Jet Healthcare is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 86.00%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 1.18 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.57 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Samco Special Opportunities Fund Regular Growth
    NA
    • Amount Invested (Cr.) 3.95
    • % of AUM 2.44
    TrustMF Small Cap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 18.44
    • % of AUM 1.90
    UTI Small Cap Fund Regular Growth
    2/5
    • Amount Invested (Cr.) 45.80
    • % of AUM 1.01
    WhiteOak Capital Pharma and Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 1.88
    • % of AUM 0.56
    Samco Multi Cap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 1.17
    • % of AUM 0.32
    Blue Jet Healthcare Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-14Audited Results, Final Dividend & Others
    2025-01-29Quarterly Results
    2024-10-29Quarterly Results
    2024-08-06Quarterly Results
    2024-05-25Audited Results & Dividend
    About the company Blue Jet Healthcare
    • Industry
    • ISININE0KBH01020
    • BSE Code544009
    • NSE CodeBLUEJET
    Blue Jet Healthcare Limited is an India-based company, specializing in manufacturing integrated contrast media, artificial sweeteners and its salts, as well as niche pharmaceutical intermediaries and active pharmaceutical ingredients (APIs). The Company serves as a business-to-business (B2B) company. Its integrated contrast media intermediate product categories include x-ray contrast media intermediates and MRI contrast media intermediates. Its x-ray contrast media intermediates include non-ionic APIs and ionic APIs. It manufactures saccharin and supplies to healthcare, pharma, animal feed, food and beverages industries globally. The Company's offerings include insoluble saccharin, saccharin sodium and insoluble saccharin. Its advance pharmaceutical intermediates and API products include Vanillic Acid, Docusate Sodium and TosMIC. It offers end-to-end integrated solutions from process development to commercialization of NCEs, advance intermediates, APIs and building blocks.
    • Management Info
    • Akshay AroraExecutive Chairman of the Board
    • Ganesh KaruppannanChief Financial Officer
    • Vimalendu SinghChief Operating Officer
    • Sweta PoddarCompliance Officer, Company Secretary
    • Shiven AroraManaging Director, Executive Director
    • Popat KedarExecutive Whole-Time Director
    • Naresh ShahExecutive Director
    Blue Jet Healthcare Share Price FAQs

    Blue Jet Healthcare is trading at 907.75 as on Fri Jul 11 2025 10:15:28. This is -0.87% lower as compared to its previous closing price of 915.75.

    The market capitalization of Blue Jet Healthcare is 15746.32 Cr as on Fri Jul 11 2025 10:15:28.

    The 52 wk high for Blue Jet Healthcare is 985.60 whereas the 52 wk low is 400.05

    Blue Jet Healthcare can be analyzed on the following key metrics -

    • TTM P/E: 50.28
    • Sector P/E: 22.90
    • Dividend Yield: 0.13%
    • D/E ratio: 0.02

    Blue Jet Healthcare reported a net profit of 305.20 Cr in 2025.

    The Mutual Fund Shareholding was 0.62% at the end of 31 Mar 2025.